drugset / Trial / NCT06930976

Tracing Of Real-time glu13Cose Metabolism in Human Immune Cells

NCT06930976 ↗

Recruiting 12 enrolled Vanderbilt University Medical Center
NaSingle-groupOpen-labelBasic science

Summary

The purpose of this study is to understand how cells of the immune system use the common sugar glucose to fuel energy production and as a building block within the cell. Investigators will intravenously infuse a non-radioactive glucose tracer into participants over a few hours and collect immune cells from the blood to track uptake and usage of this glucose within these immune cells.

Timeline

Start
2025-10-01
Primary completion
2027-06-30
Completion
2027-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject 13C6-Glucose Unknown — Intravenous